0001179110-19-013163.txt : 20191227
0001179110-19-013163.hdr.sgml : 20191227
20191227165904
ACCESSION NUMBER: 0001179110-19-013163
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191224
FILED AS OF DATE: 20191227
DATE AS OF CHANGE: 20191227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manning Anthony M.
CENTRAL INDEX KEY: 0001716468
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 191314062
MAIL ADDRESS:
STREET 1: C/O PALATIN TECHNOLOGIES, INC.
STREET 2: 4B CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2019-12-24
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001716468
Manning Anthony M.
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Common Stock
2019-12-24
4
M
0
28437
12.58
A
33880
D
Common Stock
2019-12-24
4
M
0
16258
13.02
A
50138
D
Common Stock
2019-12-24
4
M
0
6750
10.83
A
56888
D
Common Stock
2019-12-24
4
S
0
51445
20.00
D
5443
D
Stock Option(Right to Buy)
12.58
2019-12-24
4
M
0
12451
0
D
2016-11-19
2023-02-19
Common Stock
12451
0
D
Stock Option(Right to Buy)
13.02
2019-12-24
4
M
0
14804
0
D
2018-02-18
2025-02-18
Common Stock
14804
73
D
Stock Option (Right to Buy)
13.02
2019-12-24
4
M
0
1454
0
D
2018-02-18
2025-02-18
Common Stock
1454
5841
D
Stock Option(Right to Buy)
12.58
2019-12-24
4
M
0
15986
0
D
2017-02-19
2025-05-20
Common Stock
15986
0
D
Stock Option (Right to Buy)
10.83
2019-12-24
4
M
0
6750
0
D
2018-05-09
2026-02-09
Common Stock
6750
1499
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person December 14, 2018.
/s/ R. Mark Chamberlin as attorney in fact
2019-12-27